Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab.
Br J Haematol
; 196(1): e11-e14, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34405400
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purpura, Thrombotic Thrombocytopenic
/
Fibrinolytic Agents
/
Single-Domain Antibodies
/
BNT162 Vaccine
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Female
/
Humans
Language:
En
Journal:
Br J Haematol
Year:
2022
Document type:
Article
Affiliation country:
Canadá
Country of publication:
Reino Unido